Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07065747 · ClinicalTrials.gov registry record
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
A clinical trial of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA), sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT07065747: Recruiting study of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA), sponsored by Oregon Health and Science University.
NCT07065747 is a study of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA) that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 125 participants, below the 2,164-participant average among 21 other Sarcoidosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07065747, a study of Sarcoidosis and Juvenile Idiopathic Arthritis (JIA), is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.
Primary Outcome
Anterior Chamber (AC) cells will be identified from OCT images by computer algorithms. AC cell number counted by OCT will be correlated with slit lamp grading. Cell size \& other characteristics identified from OCT images will be associated with different uveitis diagnostic categories. The Standardization of Uveitis Nomenclature (SUN) grading system (scale: 0 = none to 4+ = severe) will be used to compare OCT-derived quantification against slit-lamp grading performed by attending physicians.
Conditions Studied
Study Locations (1)
Oregon
- Casey Eye Institute - Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-12 |
What NCT07065747 shows while recruiting
NCT07065747 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 2,164-participant average among 21 other Sarcoidosis trials with a reported enrollment target (94% lower).
The record links to 8 conditions, with Sarcoidosis appearing as the primary indexed condition, and to 0 interventions.
NCT07065747 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT07065747 about?
NCT07065747 is a clinical study titled "Quantification & Classification of Inflammatory Cells in Uveitis Using OCT". The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. An...
What is the current status of trial NCT07065747?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2024-09-01. Estimated completion is 2026-12.
What conditions does trial NCT07065747 study?
This clinical trial studies the following conditions: Sarcoidosis, Juvenile Idiopathic Arthritis (JIA), Birdshot Chorioretinitis, Behcet Disease, Posterior Vitreous Detachment.
Who is sponsoring clinical trial NCT07065747?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07065747 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07065747's enrollment target sits among peer trials
125 11th of 21 higher than 11 of 21 other Sarcoidosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoidosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Cardiac Sarcoidosis Randomized Trial
RECRUITING · Phase 3
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
RECRUITING
-
Vitamin D Homeostasis in Sarcoidosis
RECRUITING · Phase 4
-
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI